Annual report
3079.TEDINET S100TVMM
Period2023-04-01 → 2024-03-31
Filed2024-07-01
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥47.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥45.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥41.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥44.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥653m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥663m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥376m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥173m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥936m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥863m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥572m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥792m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥22.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥23.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥22.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥13.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥14.3bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥7.5bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥8.6bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2022-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.2bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥423m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥397m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥477m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥362m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥312m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥245m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥235m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥274m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥747m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥16.58 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.56 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.6 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.04 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.33 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.5 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥880.72 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥894.19 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥828.27 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥767.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥735.76 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.6% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.9% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,780,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 316 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 319 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 328 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 330 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 322 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 17
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥4.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥4.1bn |
| Arrhythmia Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥39.3bn |
| Arrhythmia Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥39.3bn |
| Ischemia Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| Ischemia Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥41.8bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥41.8bn |
| Total Of Reportable Segments And Otherssegment total | employees | at 2024-03-31 | 316 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Arrhythmia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Arrhythmia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Ischemia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| Ischemia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥43.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥43.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 942
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0130 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 134400 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0129 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 132000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0126 | |
| Number of shares held | CurrentYearInstant_No11MajorShareholdersMember | 132000 | |
| Shareholding ratio | CurrentYearInstant_No11MajorShareholdersMember | 0.0126 | |
| Number of shares held | CurrentYearInstant_No12MajorShareholdersMember | 132000 | |
| Shareholding ratio | CurrentYearInstant_No12MajorShareholdersMember | 0.0126 | |
| Number of shares held | CurrentYearInstant | 7269000 | |
| Shareholding ratio | CurrentYearInstant | 0.6960 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 335400 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 104400 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 10440000 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 4600 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 10780000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 104400 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 335400 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 335400 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0311 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 335400 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 335400 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0311 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 522227000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 50.00 | |
| Number of male directors and other officers | FilingDateInstant | 9 | |
| Number of female directors and other officers | FilingDateInstant | 1 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000ShibasakiHiroshiMember | 89400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000HatanoTakeshiMember | 23800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000MiyamotoSatoshiMember | 3100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000UchidaYoshinoriMember | 42600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000SuwaSatoshiMember | 11000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000DogakinaiShigeharuMember | 1100 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000SugiyamaSumioMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000MiyagawaTakeshiMember | 37700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000NojimaToruMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E03005-000TanoueAkikoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 208700 | |
| Audit fees reporting company | Prior1YearDuration | 32000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 31500000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember | 142376000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |